Protective role of vitamin E on drug induced neuropathy

Regina Roy, C. G. Hema, N. Geetha, Ravi Indla, Thangam Chinnathampi


Background: The objective of this study was to look into the protective role of vitamin E (Vit.E) on drug‑induced neuropathy.

Methods: The study involved 18 albino rats; rats were divided into 3 Groups; Group 1 ‑ control (n = 6), Group 2 - anti‑leukemic drugs treated rats (n = 6), Group 3 - anti‑leukemic drugs and Vit.E treated rats (n = 6). Anti‑leukemic drugs which included vincristine (VCR), L‑asparaginase (L‑Asp), doxorubicin (ADR), prednisolone (PDN), were administered to Group 2 and Group 3 rats according to acute lymphoblastic leukemia treatment regimen (MCP841). Group 3 rats were given in addition to the anti‑leukemic drugs, Vit.E (100 mg/kg bodyweight/orally) daily. Tests for neuropathy were done using tail clip method, tail flick method, hot plate method on the 2nd week and tail clip method on 4th week of therapy.

Results: At the end of 2nd week by tail clip method and tail flick method the mean reaction time of the anti‑leukemic drugs alone treated group (Group 2) was increased showing the development of neuropathy. The mean reaction time of the anti‑leukemic drugs + Vit.E treated group (Group 3) showed a reduction in the reaction time, showing the protective role of Vitamin E. Hot plate method done at the end of 2nd week showed a decrease in mean reaction time in Group 2 rats compared with Group 3. This could be due to the hyperthermalgesia by VCR. Group 3 was protected by Vit.E.

Conclusion: Observations showed a protective role of Vit.E on drug induced neuropathy.


Antioxidants, Anti leukemic drugs, Vitamin E, Hyperthermalgesia, MCP841 protocol

Full Text:



Margolin JF, Poplack DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editor. Principles and Practice of Paediatric Oncology. 3rd Edition. Philadelphia, PA: Lippincott Raven; 1997: 409 46.

Miller R. Epidemiology of leukemia. In: Neth R, Gallo R, Hufschneider P, Marnweiler K, editors. Modern Trends in Human Leukemia III. New York: Springer Verlag; 1979.

Vaidya SJ, Advani SH, Pai SK, Nair CN, Kurkure PA, Saikia TK, et al. Survival of childhood acute lymphoblastic leukemia: results of therapy at Tata Memorial Hospital, Bombay, India. Leuk Lymphoma. 1996;20(3 4):311 5.

Sikic BI. The rational basis of cancer chemotherapy. In: Craig CR, Stitzel RE, editor. Modern Pharmacology. 3rd Edition. Boston: Little Brown; 1990: 778 82.

Tanner KD, Levine JD, Topp KS. Microtubule disorientation and axonal swelling in un myelinated sensory axons during vincristine induced painful neuropathy in rat. J Comp Neurol. 1998;395(4):481 92.

Sandler SG, Tobin W, Henderson ES. Vincristine induced neuropathy. A clinical study of fifty leukemic patients. Neurology. 1969;19(4):367 74.

Macdonald DR. Neurotoxicity of chemotherapeutic agents. In: Perry MC, editor. The Chemotherapy Source Book. 2nd Edition. Philadelphia, PA: Williams & Wilkins; 1996: 752 4.

Chabner BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th Edition. New York: McGraw Hill; 1996: 1233 87.

Aley KO, Reichling DB, Levine JD. Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience. 1996;73(1):259 65.

Mayes PA. Structure and function of the lipid soluble vitamins. Harper’s Biochemistry. Norwalk: Appleton and Lange; 1993: 592.

Marcus R, Coulston AM. Fat soluble vitamins. Goodman and Gilman’s the Pharmacological Basis of Therapeutics. 9th Edition. New York, NY: McGraw Hill; 1996: 1585 8.

Venditti P, Masullo P, Di Meo S, Agnisola C. Protection against ischemia reperfusion induced oxidative stress by vitamin E treatment. Arch Physiol Biochem. 1999;107(1):27 34.

Bianchi C, Franceschini J. Experimental observations on Haffner’s method for testing analgesic drugs. Br J Pharmacol Chemother. 1954;9(3):280 4.

Ghosh MN. Evaluation of analgesic agents. Fundamentals of experimental Pharmacology. Calcutta: Scientific Book Agency; 1984: 144 5.

Medhi B, Prakash A. Practical Manual of Experimental and Clinical Pharmacology. 1st Edition, Chapter 18. New Delhi: Jaypee Brothers, Medical Publishers; 2010: 201 2.

D’Amour FE, Smith DL. A method for determining loss of sensation. J Pharmacol Exp Ther. 1941;72:74.

Eddy NB, Leimbach D. Synthetic analgesics. II. Dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther. 1953;107(3):385 93.